Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?

Zalatimo O, Zoccoli CM, Patel A, Weston CL, Glantz M.

Adv Exp Med Biol. 2013;779:267-89. doi: 10.1007/978-1-4614-6176-0_12. Review.

PMID:
23288644
2.

Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.

Ferrari Bravo M, De Conca V, Devoto GL, Sironi M, Mele R, Fumagalli A, Rimassa P, Rossi G, Zampogna A, Sticchi C, Gabutti G; Medical Screening Program Group.

J Prev Med Hyg. 2012 Mar;53(1):37-43.

PMID:
22803318
3.

Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis.

Mohile NA, Zoccoli CM, Glantz M.

Neurology. 2011 Mar 29;76(13):1118-20. doi: 10.1212/WNL.0b013e318212a928. Epub 2011 Feb 23. No abstract available.

PMID:
21346222
4.

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC.

Braz J Infect Dis. 2009 Apr;13(2):90-8.

5.

KPC-2-producing Klebsiella pneumoniae in Brazil: a widespread threat in waiting?

Zavascki AP, Zoccoli CM, Machado AB, de Oliveira KR, Superti SV, Pilger DA, Cantarelli VV, Barth AL.

Int J Infect Dis. 2010 Jun;14(6):e539-40. doi: 10.1016/j.ijid.2009.07.004. Epub 2009 Nov 4. No abstract available.

6.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D.

Braz J Infect Dis. 2003 Feb;7(1):44-61.

7.

Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.

Sader HS, Gales AC, Pfaller MA, Mendes RE, Zoccoli C, Barth A, Jones RN.

Braz J Infect Dis. 2001 Aug;5(4):200-14. Epub 2003 Mar 7.

8.

Comparative in vitro Activity of Meropenem Versus Other Extended-Spectrum Antimicrobial Agents Against 2,085 Clinical Isolates Tested in 13 Brazilian Centers.

Gales AC, Sader HS, Dainesi SM, Mimica I I, Sampaio J, Zoccoli C, Oplustil C, Mendes C.

Braz J Infect Dis. 1997 Dec;1(6):294-305.

PMID:
11105151
9.

Evaluation of the Antimicrobial Activity of Sparfloxacin, Relative to Other Oral Antibiotics Against 1,125 Bacterial Isolates from 10 Medical Centers in Brazil.

Mendes C, Sader H, Dainesi SM, Dias CG, Coscina A, Zoccoli C, da Silva JF, Magalhães M, Teixeira LM, Souza HH, Oplustil CP, Andrade MG, Mimiça L, Mimiça I I.

Braz J Infect Dis. 1998 Feb;2(1):18-24.

PMID:
11101907
10.

Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers.

Sader HS, Sampaio JL, Zoccoli C, Jones RN.

Braz J Infect Dis. 1999 Apr;3(2):63-79.

PMID:
11098193
11.

Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.

Mendes C, Hsiung A, Kiffer C, Oplustil C, Sinto S, Mimica I, Zoccoli C; Mystic Study Group.

Braz J Infect Dis. 2000 Oct;4(5):236-44.

PMID:
11063555
12.

Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest.

Sader HS, Mimiça I, Rossi F, Zoccoli C, Montelli AC, Sampaio JL, Segura AJ, Magalhães M, Nowakonski A, Mendes CM.

Diagn Microbiol Infect Dis. 1997 Jun;28(2):87-92.

PMID:
9239500
13.

[Central venous catheter-related infections in critically ill patients].

Diener JR, Coutinho MS, Zoccoli CM.

Rev Assoc Med Bras. 1996 Oct-Dec;42(4):205-14. Portuguese.

PMID:
9181735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk